Prof Mahesh Radhakrishnan
Senior Professor
| Department of Pharmacy
Birla Institute of Technology & Sciences, Pilani
Rajasthan
Expertise:
Neurosciences
98
Publications
4
Projects
2183
Scopus Citations
1786
CrossRef
26 Years 8 Months Total Experience
Scopus
2,183
Citations
27
h-index
CrossRef
1,786
Citations
25
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Best Poster 1st Presentation Prize
2016
DBT, ICMR and APTI Sponsored National Conference on “Contemporary Technologies in Drug Delivery and
Best Published Paper Award; Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Assoc. of Pharm. Teachers of India Conf. 2014
2014
Association of Pharmaceutical Teachers of India (APTI)
Best Published Paper Award; NN Dutta Prize (Indian Pharmacology Society Conf. 2013
2013
Indian Pharmacology Society Conf. 2013
Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award
2012
Association of Pharmaceutical Teachers of India (APTI)
Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award
2011
Association of Pharmaceutical Teachers of India (APTI)
Best Poster 2nd Presentation Prize
2014
NIPICON International Conference
Best Poster 1st Prize
2012
Pharmanext (AIPER)
Best Poster Presentation Prize
2012
Indian Pharmaceutical Association
Best Poster Presentation 1st Prize
2011
Indian Pharmacological Society International Convention
Best Poster Presentation 1st Prize
2009
Association of Pharmaceutical Teachers of India (APTI), Conference
Best Poster Presentation 1st Prize
2008
Indian Pharmacological Society International Convention
Best Paper Published
2005
Indian Pharmaceutical Congress Annual Convention
PC Dandiya Award
2011
Indian Pharmacological Society International Convention
Community & Membership
No Data Found
There is currently nothing to display here.
Indian Pharmacological Society
Life TimeAssociation of Pharmaceutial Teachers of India
Life TimePersonal Details
Doctor of Philosophy
1997
N/A
Master of Pharmacy
1989
N/A
Senior Professor
Nov 2021 – Present
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Professor
Jan 2010 – Nov 2021
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Associate Professor
Jan 2005 – Jan 2010
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Assistant Professor
Jan 2000 – Jan 2005
Birla Institute of Technology & Sciences, Pilani
| Department of Pharmacy
Medical and Health Sciences
Scholarly Work
Design and synthesis development of new class of anti-malarial agents
OtherSynthesis and pharmacological evaluation of novel phosphodiesterase 4 inhibitors for their anti-depressant and anxiolytic potential
OtherDesign and synthesis development of new class of anti-malarial agents
OtherNovel Neuro - Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive Dysfunction and CCIE: Design, Synthesis and Screening of Potential Serotonergic Modulators
OtherDesign Synthesis and pharmacological evaluation of novel serotonergic 5HT3 receptor antagonist as potential agents for the treatment of cancer chemotherapy induced emesis
Behavioural Neuropharmacological Studies of Selected Serotonin Type-3 Receptor Antagonists as Potential Anti-depressants
Neurobehavioural and Neurochemical Evaluation of Selected Monoaminergic Modulators in Animal Models of Comorbid Depression and Anxiety
Novel Quinoxaline Carboxamides: Design, Synthesis And Neuro-Pharmacological Evaluation as Anti-depressants, Anxiolytic And in the Management of Cancer Chemotherapy-Induced Nausea and Vomiting
Behavioural and Neuropharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression, Anxiety and Related Disorders such as Cancer Chemotherapy Induced Nausea and Vomiting (CINV
Design, Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase-IV inhibitors for their Anti-depressant and Anxiolytic Potential
Behavioral and Neuropharmacological Screening of Phosphodiesterase4 (PDE4) Inhibitors for Anti-depressant and Anxiolytic Potential
Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators
Behavioral and neuro-pharmacological screenig of potential serotonergic modulators for depression co-morbid with obesity
Behavioral and neuro-pharmacological screening of potential serotonergic ligands for the management of depression and anxiety co-morbid with type-1 diabetes mellitus
Design synthesis and screening of potential anti- malarial agents
Isolation and charcterization of genetic variants of betacasein protein (A1/A2) and study their impact on early precipitation of osteoporosis
A METHOD FOR DETERMINING A1/A2 GENOTYPE OF MILCH ANIMALS
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Application No. :
201911018953
Filed :
13-05-2019
Published :
20-11-2020
Published
NON-ENZYMATIC METHOD FOR LARGE SCALE ISOLATION OF ß-CASEIN FROM MILK
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Patent No. :
47/2020
Filed :
13-05-2019
Published :
20-11-2020
Published
PDE4 INHIBITOR COMPOUNDS FOR TREATING ANTI-DEPRESSANT AND ANXIOLYTIC RELATED DISORDERS
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Patent No. :
47/2015
Filed :
15-05-2014
Published :
20-11-2015
Granted
Scholarly Publications
Synthesis and antiinflammatory activity of 1,3 disubstituted indolinones
Scopus: 6
Microwave-induced Mannich reaction - Synthesis of some Mannich derivatives of p-aminophenol
Scopus: 6
Pharmacophore based synthesis of 3-chloroquinoxaline-2-carboxamides as serotonin3 (5-HT3) receptor antagonist
Open Access
Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8- naphthyridine-3-carbonitrile as a new class of serotonin 5-HT 3 receptor antagonists
Cancer chemotherapy-induced nausea and vomiting: Role of mediators, development of drugs and treatment methods
Scopus: 41
Microwave-assisted solvent-free synthesis of 3-[(4-substituted piperazin-1-yl)alkyl] imidazo[2,1-b][1,3]benzothiazol-2(3H)-ones as serotonin3 (5-HT3) receptor antagonists
Scopus: 12
Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonists
Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: A model of comorbid depression and anxiety?
Showing 1 to 8 of 98 publications